Sample6 Earns U.S. Patent for Listeria Detection Assay
Sample6 has announced that it was granted a new patent enabling extremely rapid and sensitive bacterial detection for the genus Listeria through the use of the proprietary phage-based luminescence assay.
The company was awarded a patent by the U.S. Patent and Trademark Office, strengthening the patent protection of its lead DETECT/L™ product. U.S. Patent No. 9,340,817, entitled "Methods of making recombinant phage, compositions and articles of manufacture of same for bacterial detection" discloses for the first time a cocktail of bacteriophages that in total can detect all species of the genus Listeria within a single work shift. Additionally, the patent discloses further invention in the field of synthetic biology to add to Sample6's unique synthetic biology engineering toolbox.